Community-acquired Pneumonia

• FDA approval · 2007-05-09
  FDA Approved: CEFDINIR — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approves Teva's cefdinir product CEFDINIR under an Original Application (ANDA). This generic antibiotic is approved for common infection…

• FDA approval · 2007-05-07
  FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)

  The FDA approved Lupin Pharmaceuticals' supplemental application for CEFDINIR, a generic cefdinir product, authorizing continued/expanded ma…

• FDA approval · 2007-05-04
  FDA Approved: CEFDINIR — Original Application (Teva Pharmaceuticals USA, Inc.)

  FDA approves Teva's original application for CEFDINIR (cefdinir), a generic cephalosporin antibiotic.

• FDA approval · 2007-04-26
  FDA Approved: LINEZOLID — Supplemental Application (Mylan Pharmaceuticals Inc.)

  The FDA approved a supplemental application for LINEZOLID submitted by Mylan Pharmaceuticals Inc., associated with updates to the product’s …

• FDA approval · 2007-04-06
  FDA Approved: CEFDINIR — Original Application (Sandoz Inc)

  FDA approved Sandoz's original ANDA for cefdinir, a generic cephalosporin antibiotic.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-04-03
  FDA Approved: TYGACIL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

  The FDA approved a supplemental application for TYGACIL (tigecycline) by Wyeth Pharmaceuticals (a Pfizer subsidiary), indicating regulatory …

• FDA approval · 2006-06-19
  FDA Approved: AMOXICILLIN — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma Pharmaceuticals USA Inc. to market amoxicillin under an Original Application (ANDA). The approval covers a generic amoxic…